People

Hank Safferstein
Hank Safferstein serves as More Team Members with UPMC Enterprises, UPMC’s innovation, commercialization and corporate venture investment division. The organization’s current public team directory and individual biography verify this affiliation. Hank combines scientific, legal and business training, including a doctorate in neurobiology. His current Enterprises biography identifies him as Generian Pharmaceuticals CEO and a former founding CEO of Cognition Therapeutics, where he helped advance Alzheimer’s research into clinical development. Earlier roles included biotechnology business development and NIH technology transfer.
Roles
UPMC Enterprises
CurrentMore Team Members